ArticleArthritis & rheumatology (Hoboken, N.J.)2017

Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi-Database Cohort Study.

Seoyoung C Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.